Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ehab Mosaad Abdelghany"'
Autor:
Hossam Abdel Rahman, Refaei Belal Ibrahim, Haleem J. Rasool, Mohamed Youssef Deibas, Ahmed Allithy, Reyad Dada, Jamal Zekri, Kamel Farag, Imran Ahmad, Mohamed Kamal Kamel, Ehab Mosaad Abdelghany, Azhar Nawaz
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(8)
Background Febrile neutropenia (FN) is a life-threatening complication of Docetaxel-based chemotherapy regimens (DBRs). Prophylactic granulocyte-colony stimulating factor (G-CSF) can reduce the risk of FN. This study investigated the effect of G-CSF
Autor:
Reyad Dada, Jalil Ur Rehman, Jamal Zekri, Mouhammed Kelta, Rawan Al-Saadi, Ehab Mosaad Abdelghany, Zahid Amin Khan
Publikováno v:
Tumori Journal. 104:471-475
Purpose: High-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) is used to treat patients with relapsed Hodgkin’s lymphoma. In this retrospective study we report our experience with patients who underwent HDCT and ASCT. Metho
Publikováno v:
The Oncologist. 23:e164-e165
Publikováno v:
Blood. 132:5357-5357
Objectives: The diagnosis of cancer significantly affects quality of life (QoL) of patients. Admission on wards and spending several days far from home to receive chemotherapy, especially in young patients with Hodgkin lymphoma (HL), might negatively
Publikováno v:
Journal of Clinical Oncology. 36:e18070-e18070
e18070Background: Capecitabine, an oral 5-fluorouracil (5FU) derivate, is widely used as replacement for 5FU in many chemotherapy regimens administered in patients with different gastrointestinal t...
Autor:
Imran Ahmad, Haleem J. Rasool, Reyad Dada, Ahmed Allithy, Jamal Zekri, Mohamed Youssef Deibas, Kamel Farag, Hossam Abdel Rahman, Ehab Mosaad Abdelghany, Refaei Belal Ibrahim, Mohamed K. Kamel, Azhar Nawaz
Publikováno v:
Journal of Clinical Oncology. 36:e12516-e12516
e12516Background: Primary prophylactic Granulocyte Colony Stimulating Factor (PP-GCSF) is recommended for patients receiving single agent docetaxel (SAD) and docetaxel combination regimens (DCR) to...
Autor:
Imran Ahmad, Reyad Dada, Ehab Mosaad Abdelghany, Husna Munsoor, Syed Mustafa Karim, Jamal Zekri
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Background: A substantial number of cancer patients receive chemotherapy until the end of life (EoL). Various factors have been shown to be associated with receipt of chemotherapy until near death. In this study, we determine our average time from la
Autor:
Baker bin Sadiq, Elshami Elamin, Sawsan Bassi, Syed Mustafa Karim, Jamal Zekri, Hossam Abdelrahman, Ehab Mosaad Abdelghany
Publikováno v:
Journal of Palliative Care & Medicine.
Background: It is believed in some Middle Eastern (ME) cultures that disclosure of bad news to cancer patients may cause loss of hope. This is often used to justify withholding such news. In this study, we examine cancer patients ‘preference regard
Autor:
Ian Kerr, Syed Mustafa Karim, Aboelkhair M Al-Gahmi, Ehab Mosaad Abdelghany, Reyad Dada, Imran Ahmad, Husna Munsoor, Jamal Zekri, Mohammed Iqbal Ansari, Azhar Rizvi
Publikováno v:
Journal of Clinical Oncology. 31:e20613-e20613
e20613 Background: A substantial number of cancer patients receive inpatient care at the end-of-life (EoL). Involvement of palliative care teams during the course of cancer treatment has been shown to improve quality of life (QoL) in cancer patients.